Error: Could not add to watchlist. X
+ Watchlist

Biogen Inc

BIIB:US
NASDAQ GS
277.87
USD
2.08
0.75%
As of 8:10 PM EDT 3/22/2017
Open
276.43
Day Range
274.93 - 278.54
Volume
1,333,588
Previous Close
275.79
52Wk Range
205.43 - 307.33
1 Yr Return
18.19%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
276.43
Day Range
274.93 - 278.54
Volume
1,333,588
Previous Close
275.79
52Wk Range
205.43 - 307.33
1 Yr Return
18.19%
YTD Return
6.38%
Current P/E Ratio (TTM)
14.68
Earnings per Share (USD) (TTM)
18.92
Market Cap (b USD)
60.007
Shares Outstanding (m)
215.952
Price/Sales (TTM)
5.30
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.08%
% Price Change
+0.07%
Profile
Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company products address diseases such as multiple sclerosis, non-hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.
Address
225 Binney Street
Cambridge, MA 02142
United States
Phone
1-781-464-2000
Show More